Brief: Kang Stem Biotech receives patent
03/08/2017 08:48
Aug 3 (Reuters) - Kang Stem Biotech Co Ltd 217730.KQ :
* Says it receives patent about Pharmaceutical composition
comprising stem cells treated with granules of mast cells or
culture thereof for prevention and treatment of immune diseases
and inflammatory diseases
Source text in Korean: https://goo.gl/3RFop1
Further company coverage: 217730.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; Reuters Messaging:
Yinglan.Ma@thomsonreuters.com@reuters.net))
Recent news on Kang Stem Biotech
See all newsBrief: Kangstem Biotech To Conduct Capital Increase Of 49 Billion Won
Brief: Kangstem Biotech To Conduct Capital Increase Of 35.7 Billion Won
Brief: Kang Stem Biotech to invest 8.76 bln won in facilities extension
Brief: Kang Stem Biotech receives patent
Brief: Kang Stem Biotech raises 35.95 bln won via rights issue